Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Brennan

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Alzheimer'S Disease : JAD|July 16, 2014
Neuropsychological syndromes associated with Alzheimer's/vascular dementia: a latent class analysisDavid J Libon, Deborah A G Drabick, Tania Giovannetti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2020
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Rachael Purri, Laura Brennan, Jacqueline Rick, et al.
Applied Neuropsychology. Adult|September 24, 2015
Visuoconstructional Impairment in Subtypes of Mild Cognitive ImpairmentSamrah Ahmed, Laura Brennan, Joel Eppig, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2022
Immune contexture of paediatric cancersMeghna Das Thakur, Carl J Franz, Laura Brennan, et al.
Journal of Parkinson'S Disease|April 8, 2017
Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class AnalysisLaura Brennan, Kathryn M Devlin, Sharon X Xie, et al.
Cancer Biology & Therapy|June 13, 2014
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growthMaria B Lebron, Laura Brennan, Christopher B Damoci, et al.
BMC Cancer|March 19, 2025
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, et al.
Cancer|April 24, 2026
Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignanciesTae Min Kim, Stephen K Williamson, Kyriakos P Papadopoulos, et al.
Autism Research : Official Journal of the International Society for Autism Research|August 4, 2021
Measurement invariance of the Childhood Autism Rating Scale (CARS) across six countriesDejan Stevanovic, Floriana Costanzo, Elisa Fucà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced MelanomaOmid Hamid, Karl D Lewis, Amy Weise, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Alzheimer'S Disease : JAD|July 16, 2014
Neuropsychological syndromes associated with Alzheimer's/vascular dementia: a latent class analysisDavid J Libon, Deborah A G Drabick, Tania Giovannetti, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2020
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?Rachael Purri, Laura Brennan, Jacqueline Rick, et al.
Applied Neuropsychology. Adult|September 24, 2015
Visuoconstructional Impairment in Subtypes of Mild Cognitive ImpairmentSamrah Ahmed, Laura Brennan, Joel Eppig, et al.
European Journal of Cancer (Oxford, England : 1990)|June 6, 2022
Immune contexture of paediatric cancersMeghna Das Thakur, Carl J Franz, Laura Brennan, et al.
Journal of Parkinson'S Disease|April 8, 2017
Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class AnalysisLaura Brennan, Kathryn M Devlin, Sharon X Xie, et al.
Cancer Biology & Therapy|June 13, 2014
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growthMaria B Lebron, Laura Brennan, Christopher B Damoci, et al.
BMC Cancer|March 19, 2025
Immune modulation in solid tumors: a phase 1b study of RO6870810 (BET inhibitor) and atezolizumab (PD-L1 inhibitor)Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, et al.
Cancer|April 24, 2026
Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignanciesTae Min Kim, Stephen K Williamson, Kyriakos P Papadopoulos, et al.
Autism Research : Official Journal of the International Society for Autism Research|August 4, 2021
Measurement invariance of the Childhood Autism Rating Scale (CARS) across six countriesDejan Stevanovic, Floriana Costanzo, Elisa Fucà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced MelanomaOmid Hamid, Karl D Lewis, Amy Weise, et al.
Pageof 5